Blog

IMITA® device earns nomination in the DCB Innovation Challenge 2022!

13 Apr 2022

The Captixbio team are thrilled to announce that the IMITA® device has been nominated as one of the TOP 20 Diabetes Devices of the DCB Innovation Challenge 2022!

This challenge recognises the critical role technology and its development, plays in improving the lives of those with T1D. It provides the opportunity for innovative solutions and technology to be presented and be shared with global experts in the industry, receive expertise and support from this network, and potential access to critical funding to accelerate the development of technology and solutions with the ultimate shared goal of changing and making better diabetes management!

We will keep you updated on our journey through this challenge. For more information on it hit the link below.

https://www.dcb-innovation-challenge.com